Oral Oncology
Volume 36, Issue 1 , Pages 61-66 , January 2000

Head and neck squamous cell carcinoma lines produce biologically active angiogenic factors

Received 23 February 1999 ,Revised 6 April 1999

References 

  1. Folkman J. The role of angiogenesis in tumor growth. Sem Cancer Biol. 1992;3:65–71
  2. Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671–674
  3. Weidner N, Semple JP, Welch W, Folkman J. Tumor angiogenesis and metastasis. Correlation in invasive breast carcinoma. N Eng J Med. 1991;324:1–8
  4. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularization to metastasis of non small cell lung cancer. Lancet. 1992;340:145–146
  5. Vartanian RK, Weidner N. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor proliferation in breast carcinoma. Am J Pathol. 1994;144:1188–1194
  6. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of fibroblast growth factor 2. Endocr Rev. 1997;18:26–45
  7. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:4–25
  8. Moscatelli D, Presta M, Rifkin DB. Purification of a factor from human placenta that stimulates endothelial cell protease production, DNA synthesis, and migration. Proc Natl Acad Sci USA. 1986;83:2091–2095
  9. Keegan K, Johnson DE, Williams LT, Hayman MJ. Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc Natl Acad Sci USA. 1991;88:1095–1099
  10. Partanen J, Makela TP, Eerola E, Korhonen J, Hirvonen H, Claesson-Welch L, et al. FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J. 1991;10:1347–1354
  11. Rojeli S, Klagsbrun M, Atzmon R, Kurokawa M, Haimovitz A, Fuks Z, et al. Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells. J Cell Biol. 1989;109:823–831
  12. Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: deposition into the subepithelial extracellular matrix and bioactivity of ECM bound VEGF. Mol Biol Cell. 1993;4:1317–1326
  13. Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in epithelial cells. Identification of a 5′ enhancer. Circ Res. 1995;77:638–643
  14. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia inducible factor 1. Mol Cell Biol. 1996;16:4604–4613
  15. Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Comm. 1992;189:824–831
  16. Phillips GD, Stone AM, Jones BD, Schultz JC, Whitehead RA, Knighton DR. Vascular endothelial growth factor (rhVEGF165) stimulates angiogenesis in the rabbit cornea. In Vivo. 1995;8:961–965
  17. Mustonen T, Alitalo K. Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol. 1995;129:895–898
  18. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439–442
  19. Shalaby F, Ho J, Stanford WL, Fischer KD, Schuh AC, Schwartz L, et al. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell. 1997;89:981–990
  20. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer. 1996;77:858–863
  21. Oku T, Tjuvajev JG, Miyagawa T, Sasajima T, Joshi A, Joshi R, et al. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts. Cancer Res. 1998;58:4185–4192
  22. Borgstrom P, Hillan KJ, Sriramarao P, Ferrara N. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibodies: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res. 1996;56:4032–4039
  23. Roberts WG, Palade G. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci. 1995;108:2369–2379
  24. Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers. Int J Cancer. 1988;41:184–197
  25. Hu L, Crowe DL, Rheinwald JG, Chambon P, Gudas LJ. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res. 1991;51:3972–3981
  26. Vo HP, Lee MK, Crowe DL. α2β1 integrin signaling via the mitogen activated protein kinase pathway modulates retinoic acid dependent tumor cell invasion and transcriptional downregulation of matrix metalloproteinase 9 activity. Int J Oncol. 1998;13:1127–1134
  27. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, et al. Fibroblast growth factor 2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol. 1998;141:1659–1673
  28. Gille J, Swerlick RA, Caughman SW. Transforming growth factor alpha induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2 dependent DNA binding and transactivation. EMBO J. 1997;16:750–759
  29. Arbiser JL, Moses MA, Fernandez CA, Ghiso N, Cao Y, Klauber N, et al. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci USA. 1997;94:861–866
  30. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, et al. Tumor induction of VEGF promoter activity in stromal cells. Cell. 1998;94:715–725
  31. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, et al. Role of HIF-1α in hypoxia mediated apoptosis, cell proliferation, and tumor angiogenesis. Nature. 1998;394:485–490
  32. Zhong H, Agani F, Baccala AA, Laughner E, Rioseco-Camacho N, Isaacs WB, et al. Increased expression of hypoxia inducible factor 1α in rat and human prostate cancer. Cancer Res. 1998;58:5280–5284
  33. Seko Y, Takahashi N, Tobe K, Kadowaki T, Yazaki Y. Hypoxia and hypoxia/reoxygenation activate p65PAK, p38 mitogen activated protein kinase (MAPK), and stress activated protein kinase (SAPK) in cultured rat cardiac myocytes. Biochem Biophys Res Comm. 1997;239:840–844
  34. Tsang DK, Crowe DL. The mitogen activated protein kinase pathway is required for proliferation but not invasion of human squamous cell carcinoma lines. Int J Cancer. 1999;15:519–523

PII: S1368-8375(99)00052-4

Oral Oncology
Volume 36, Issue 1 , Pages 61-66 , January 2000

Article Tools

* Image Usage & Resolution